Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1995 Sep;59(3):248-52.
doi: 10.1136/jnnp.59.3.248.

Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study

L H Van den Berg  1 , H Kerkhoff, P L Oey, H Franssen, I Mollee, M Vermeulen, F G Jennekens, J H Wokke
Affiliations
Clinical Trial

Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study

L H Van den Berg et al. J Neurol Neurosurg Psychiatry. 1995 Sep.

Abstract

The effect of high dose intravenous immunoglobulin (IVIg) treatment was studied in six patients with multifocal motor neuropathy (MMN). All patients responded to treatment (0.4 g/kg for five consecutive days) in an open trial. The effect of IVIg treatment was confirmed for each patient in a single patient, double blind, placebo controlled trial. Four patients received two IVIg treatments and two placebo treatments, and two patients received one IVIg and one placebo treatment in a randomised order. Five out of six patients responded to IVIg but not to placebo. One patient responded to IVIg in the same manner as to placebo treatment. Thus IVIg treatment can lead to improvement of muscle strength in patients with MMN.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Neurol Neurosurg Psychiatry. 1991 Mar;54(3):244-7 - PubMed
    1. Neurology. 1992 Mar;42(3 Pt 1):497-505 - PubMed
    1. Neurology. 1993 Mar;43(3 Pt 1):537-44 - PubMed
    1. Lancet. 1986 Mar 29;1(8483):726-8 - PubMed
    1. J Neurol Neurosurg Psychiatry. 1994 Nov;57(11):1303-7 - PubMed

Publication types

Substances